Hinge Health (HNGE) Turns Profitable In Q3, Is The Stock Still Undervalued?

Hinge Health (HNGE) just delivered third quarter results that put hard numbers around its digital care model, with sales of US$234.97 million and net income of US$57.4 million, replacing a loss a year earlier.

On the market side, Hinge Health shares now trade at US$115.76, with a 30 day share price return of 18.29% and a 90 day gain of 29.59%, while the 1 year total shareholder return of 160.19% indicates strong recent momentum in the stock.

Scan beyond Hinge Health and compare this digital care story with other fast moving healthcare and AI plays using our curated list of 35 healthcare AI stocks.

Hinge Health has surged after turning profits, yet the share price still sits well below some valuation estimates. Is the real fair value closer to current market pricing or to that higher intrinsic range?

Most Popular Narrative: 20% Undervalued

Hinge Health last closed at $115.76, while the most followed narrative pegs fair value near $145.04, which frames the current valuation gap in very clear terms for anyone weighing the recent rally against long term cash flow expectations.

Hinge Health has quickly distinguished itself as one of the most successful IPOs of 2025, combining rapid revenue growth, widening margins, and a scalable AI driven care model. The company’s focus on musculoskeletal (MSK) health, covering prevention, acute injury, chronic pain, and post surgical recovery, has resonated with employers and insurers, driving adoption across millions of contracted lives.

See why 3 investors see Hinge Health as 20% undervalued.

Result: Fair Value of $145.04 (UNDERVALUED)

Still, Hinge Health relies heavily on employer and payer relationships, and any tighter reimbursement rules or compliance setbacks could quickly challenge that underpriced fair value story.

Find out about the key risks to this Hinge Health narrative.

Next Steps

You may feel that Hinge Health is either getting ahead of itself or still underappreciated despite the recent surge. Act quickly, test the assumptions, and judge the potential upside and downside for yourself by reviewing the 4 key rewards.

Looking for more Hinge Health sized opportunities?

Do not stop with Hinge Health. Use the Simply Wall Street Screener to quickly surface fresh stock ideas before they move out of reach.

• Target potential mispricings by scanning a curated 39 high quality undervalued stocks that combine quality fundamentals with more modest market expectations.
• Build a steadier income stream by reviewing a focused 8 dividend fortresses that may suit investors who prioritise yield and staying power.
• Guard your capital more carefully by filtering for a 29 resilient stocks with low risk scores that emphasises resilient balance sheets and lower overall risk profiles.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com